StopDown
Funding · 24 February 2026Oncare₹27 CrDistributed oncology care network

Oncare raises ₹27 crore in Series A round

By · Editor ·

Series AFounded 2023
  • Oncare runs a distributed oncology care model partnering with accredited hospitals
  • It raised ₹27 crore in Series A led by Sky Impact Capital with Huddle Ventures and others
  • The funds will expand into metro and Tier-2/3 cities and improve technology for patient care

What happened

  • Oncare raised ₹27 crore in a Series A funding round.
  • The round was led by Sky Impact Capital.
  • Participating investors included Huddle Ventures, Lotus Herbal Group, SteerX, and Tremis Capital.
  • The company will use the funds to expand into metro markets and Tier-2/Tier-3 cities.
  • It will also invest in technology to improve clinical operations, care coordination, and patient experience.
  • Oncare operates a distributed oncology care model that partners with accredited hospitals.
  • The model integrates medical, surgical, and radiation oncology services.

Why it matters

  • India's oncology care market is projected to reach ₹43,000 crore by FY28, growing at a CAGR of about 14%.
  • Access to cancer treatment is uneven, with capacity concentrated in large hospitals.
  • Indian healthtech startups raised nearly $700 million in 2025.
  • Other funded oncology startups include 4baseCare, Everhope Oncology, and MOC Cancer Care.

The business

  • Oncare was founded in 2023 by Amar Sneh and Deepak Kumar.
  • It operates four centres across Delhi NCR.
  • The company uses a capex-light model to build a national oncology network.
  • It focuses on affordable, standardised, and transparent cancer care.
  • Oncare integrates with insurance to make treatment accessible.
  • It partners with accredited hospitals to deliver care.

The founders

Amar Sneh

Co-founder

Deepak Kumar

Co-founder
  • Co-founder of Oncare.
  • Stated that the company aims to make high-quality treatment accessible, transparent, and patient-focused.

Who put in money

  • Sky Impact Capital lead — Investment firm focused on impact.
  • Huddle Ventures participated — Venture capital firm.
  • Lotus Herbal Group participated
  • SteerX participated
  • Tremis Capital participated

In numbers

₹27 croreSeries A amount · 2026
4Centres · 2026
$1 millionSeed round amount

What happens next

  • Expand into metro markets and Tier-2/Tier-3 cities.
  • Invest in technology to improve clinical operations, care coordination, and patient experience.

Earlier rounds

  • Seed · $1 million · led by Huddle Ventures

Up against

4baseCareEverhope OncologyMOC Cancer CareErlySignOneCell Diagnostics

Words to know

Series A
The first significant round of venture capital funding, typically used to scale operations.
Distributed oncology care model
A network of smaller, partnered centres providing cancer treatment instead of a single large hospital.
Capex-light model
A business model that requires low capital expenditure on physical assets, relying on partnerships instead.
CAGR
Compound annual growth rate, the average annual growth rate over a specified period.

The numbers around it

Healthcare & Life Sciences in February 2026: 18 rounds with a disclosed amount, $66.5 million in all; the biggest was Pandorum Technologies ($18M). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Tier-2 startups: A growing share of Indian startups now come from tier-2 and tier-3 cities and towns, helped by cheap data, lower costs and local problems that big-city founders do not see. Raising money and hiring senior talent remain the main hurdles.
  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Series A: Series A is usually the first large round a startup raises from venture capital funds, after it has shown that people want what it sells. In India it commonly runs from a few million dollars to about $15 million, or roughly ₹25 crore to over ₹100 crore, with founders selling about 15 to 25 percent, as of November 2026.
  • Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.

All startup news on 24 February 2026 →

Is this Oncare? Get your “Featured on StopDown” badge →